Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
79.81
206.98
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Shanghai MicroPort Endovascular MedTech Group Co Ltd stock under the Base Case scenario is 175.64 CNY. Compared to the current market price of 102.44 CNY, Shanghai MicroPort Endovascular MedTech Group Co Ltd is Undervalued by 42%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Shanghai MicroPort Endovascular MedTech Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Balance Sheet Decomposition
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Current Assets | 3.6B |
Cash & Short-Term Investments | 3B |
Receivables | 347.2m |
Other Current Assets | 224.6m |
Non-Current Assets | 927.1m |
Long-Term Investments | 121.8m |
PP&E | 343.9m |
Intangibles | 384.5m |
Other Non-Current Assets | 77.1m |
Current Liabilities | 377.6m |
Accounts Payable | 59.6m |
Accrued Liabilities | 81.9m |
Short-Term Debt | 2.5m |
Other Current Liabilities | 233.6m |
Non-Current Liabilities | 123.2m |
Long-Term Debt | 18.3m |
Other Non-Current Liabilities | 104.9m |
Earnings Waterfall
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Revenue
|
1.4B
CNY
|
Cost of Revenue
|
-335.7m
CNY
|
Gross Profit
|
1B
CNY
|
Operating Expenses
|
-331m
CNY
|
Operating Income
|
686m
CNY
|
Other Expenses
|
-69.6m
CNY
|
Net Income
|
616.4m
CNY
|
Free Cash Flow Analysis
Shanghai MicroPort Endovascular MedTech Group Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Shanghai MicroPort Endovascular MedTech Group Co Ltd's profitability score is 79/100. The higher the profitability score, the more profitable the company is.
Score
Shanghai MicroPort Endovascular MedTech Group Co Ltd's profitability score is 79/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shanghai MicroPort Endovascular MedTech Group Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Shanghai MicroPort Endovascular MedTech Group Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shanghai MicroPort Endovascular MedTech Group Co Ltd
According to Wall Street analysts, the average 1-year price target for Shanghai MicroPort Endovascular MedTech Group Co Ltd is 151.54 CNY with a low forecast of 121.2 CNY and a high forecast of 195.01 CNY.
Dividends
Current shareholder yield for Shanghai MicroPort Endovascular MedTech Group Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, production, and sale of aortic and peripheral vascular interventional medical devices. The company is headquartered in Shanghai, Shanghai and currently employs 660 full-time employees. The company went IPO on 2019-07-22. The firm's main products include the aortic stent graft system for aortic minimally invasive interventional procedures, the intraoperative stent system for open surgery, as well as the peripheral vascular stent system and peripheral balloon dilatation catheters for the treatment of peripheral vascular diseases. The firm mainly distributes its products to the domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one Shanghai MicroPort Endovascular MedTech Group Co Ltd stock under the Base Case scenario is 175.64 CNY.
Compared to the current market price of 102.44 CNY, Shanghai MicroPort Endovascular MedTech Group Co Ltd is Undervalued by 42%.